WHO ICTRP trial
Efficacy of brimonidine gel for the prevention of erythema and post inflammatory…
IRCT20150825023753N29 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20150825023753N29 |
|---|---|
| Public title | Efficacy of brimonidine gel for the prevention of erythema and post inflammatory hyperpigmentation fallowing ablative CO2 laser |
| Scientific title | Evaluation of the efficacy of brimonidine gel for the prevention of erythema and post inflammatory hyperpigmentation fallowing ablative CO2 laser |
| Primary sponsor | Shiraz University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Post laser hyperpigmentation. Postinflammatory hyperpigmentation;L81.0 |
| Interventions | Intervention 1: Intervention group: Patients will receive a combination formula (1:1 mixture of XYLA-P? and Janoberim?, ) on one side of the face, and after 30 minutes, each participant will receive a CO2 ablative laser. Intervention 2… |
| Registration date | May 3, 2025 |
| Target size | 28 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: